Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Clinical compounding pharmacies that prepare patient-specific Retatrutide prescriptions must balance the need to maintain adequate inventory against the shorter stability of reconstituted solutions
Wegovy is the brand name for semaglutide 2.4 milligrams, a once-weekly injection in the GLP-1 receptor agonist family
Retatrutide targets GIP, GLP-1, and glucagon receptors and is currently under clinical development for obesity and type 2 diabetes
The other authors declare that there are no conflicts of interest
US$ 25.94
US$ 20.88
US$ 24.28
US$ 25.50
